2018 consensus of the Taiwan Society of Cardiology and the Diabetes Association of Republic of China (Taiwan) on the pharmacological management of patients with type 2 diabetes and cardiovascular diseases

Chern-En Chiang(National Yang Ming Chiao Tung University), Jiunn-Lee Lin(National Taiwan University Hospital), Kuan‐Cheng Chang(China Medical University), Ting‐Hsing Chao(Taipei Veterans General Hospital), Chia‐Ti Tsai(National Taiwan University Hospital), Wayne Huey‐Herng Sheu(National Yang Ming Chiao Tung University), Lee‐Ming Chuang(National Taiwan University), Wei‐Shiung Yang(National Taiwan University), Kou‐Gi Shyu(Fu Jen Catholic University), Hung‐I Yeh(Çevre, Şehircilik ve İklim Değişikliği Bakanlığı), Tzung‐Dau Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Tsung‐Hsien Lin(Kaohsiung Medical University), Yen‐Wen Wu(National Yang Ming Chiao Tung University), Wei-Hsian Yin(Cheng Hsin General Hospital), Shih-Yi Lin(National Yang Ming Chiao Tung University), Shyi-Jang Shin(Kaohsiung Medical University), Jung-Fu Chen(Chang Gung University), Yi-Jen Hung(Tri-Service General Hospital), San-Jou Yeh(Chang Gung University), Yi-Heng Li(National Cheng Kung University Hospital), Kwo-Chang Ueng(Chung Shan Medical University Hospital), Shing‐Jong Lin(Taipei Medical University Hospital), Kang-Ling Wang(National Yang Ming Chiao Tung University), Chien‐Ning Huang(Chung Shan Medical University Hospital), Pao‐Hsien Chu(Chang Gung University), Hao‐Min Cheng(Taipei Veterans General Hospital), Ping‐Yen Liu(National Cheng Kung University Hospital)

Journal of the Chinese Medical Association

February 13, 2018

Cited by 22

|The Lancet|2019|3.1k

|The Journal of Clinical Endocrinology & Metabolism|2001|1.2k

|New England Journal of Medicine|2021|742

|The Lancet Neurology|2008|726

|The Lancet|2019|640

Related Papers